Hot Stock List: The Female Health (NASDAQ:FHCO), TransGlobe Energy (NASDAQ:TGA), Kentucky First Federal Bancorp (NASDAQ:KFFB), Churchill Downs (NASDAQ:CHDN), West Pharmaceutical Services (NYSE:WST)

The Female Health Company (NASDAQ:FHCO) belongs to Consumer Goods sector. Its net profit margin is 10.00% and weekly performance is -0.62%. On last trading day company shares ended up $1.59. The Female Health Company (NASDAQ:FHCO) distance from 50-day simple moving average (SMA50) is -31.34%. The Board of Directors of The Female Health Company (NASDAQ:FHCO) today announced that Karen King, the Company’s president and chief executive officer, has left the Company to pursue other interests. The Company’s chairman and former president and CEO, O.B. Parrish, has been reappointed by the board to serve as CEO.

TransGlobe Energy Corporation (NASDAQ:TGA) shares decreased -2.20% in last trading session and ended the day at $3.56. TGA Gross Margin is 69.20% and its return on assets is -2.40%. TransGlobe Energy Corporation (NASDAQ:TGA) quarterly performance is -11.47%.

On 14 July, Kentucky First Federal Bancorp (NASDAQ:KFFB) shares advanced 1.01% and was closed at $8.50. KFFB EPS growth in last 5 year was 18.10%. Kentucky First Federal Bancorp (NASDAQ:KFFB) year to date (YTD) performance is 6.62%. On July 08, Kentucky First Federal Bancorp (NASDAQ:KFFB) announced that the Company’s Board of Directors declared a cash dividend of $0.10 per share payable on August 17, 2015, to shareholders of record on July 31, 2015. Tony Whitaker, Chairman of the Company, stated that the Board of Directors determined that the payment of the dividend was appropriate in light of the Company’s capital position and financial condition.

Churchill Downs Inc. (NASDAQ:CHDN) ended the last trading day at $129.98. Company weekly volatility is calculated as 2.23% and price to cash ratio as 46.16. Churchill Downs Inc. (NASDAQ:CHDN) showed a weekly performance of 2.73%. Churchill Downs Inc. (NASDAQ:CHDN) announced Robert L. Evans will retire as Executive Chairman of the Company and as a member of management effective September 30, 2015. Evans will continue as the non-executive Chairman of the Company’s Board of Directors. These changes complete the senior executive leadership transition begun in August 2014 when William C. Carstanjen was named the Company’s Chief Executive Officer (CEO), a position Evans had held since joining the Company in August 2006.

West Pharmaceutical Services, Inc. (NYSE:WST) shares advanced 0.73% in last trading session and ended the day at $60.82. WST Gross Margin is 32.00% and its return on assets is 8.00%. West Pharmaceutical Services, Inc. (NYSE:WST) quarterly performance is 7.65%. West Pharmaceutical Services, Inc. (NYSE:WST) announced that the Company’s Board of Directors has approved a fourth-quarter 2015 dividend of $0.12 per share, a 9.1% increase over the $0.11 per share declared for each of the four preceding quarters. This is the twenty-third consecutive annual increase in the Company’s dividend. The fourth-quarter dividend will be paid on November 4, 2015 to shareholders of record as of October 21, 2015.

Leave a Reply

Your email address will not be published. Required fields are marked *